PE anti-Puromycin [2A4] and 2 more items
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0453866
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $661.50
About this award
The University of Virginia awarded a contract to BioLegend Inc. on July 3, 2026, under purchase order A207_PO-0453866 for a cumulative value of $661.00. The contract involves the procurement of three monoclonal antibody reagents for research purposes, all to be delivered to Nicholas Maximilian Hagspiel. The line items include PE anti-Puromycin [2A4] at $258.30 per unit, Brilliant Violet 510 trademark anti-human CD19 [SJ25C1] at $304.50 per unit, and FITC anti-human CD45 [HI30] at $98.70 per unit, with one unit of each item ordered.
The contract represents a direct materials purchase from a life sciences supplier specializing in immunological research products. These fluorescently-labeled antibodies are standard laboratory reagents used in flow cytometry and cell analysis applications within academic research settings. The award to BioLegend Inc., the prime contractor, fulfills the University of Virginia's procurement requirements for these specialized biological research commodities delivered within the Commonwealth of Virginia.
Line items
| Item | Total |
|---|---|
| PE anti-Puromycin [2A4] | $258.30 |
| Brilliant Violet 510TM anti-human CD19 [SJ25C1] | $304.50 |
| FITC anti-human CD45 [HI30] | $98.70 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0453866?
Contract A207_PO-0453866 was awarded to BIOLEGEND INC. by University of Virginia on July 3, 2026.
How much is contract A207_PO-0453866 worth?
Its cumulative value is $661.50.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award